Article Details
Retrieved on: 2024-07-22 19:00:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's shares rose after positive phase 1 results of oral GLP-1 agonist CT-996. See why RHHBY stock is well-positioned to create value in the ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here